Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001567619-21-012875

Director acquired 4,610 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HENNEMAN JOHN B III Director 2021-06-30 Grant or award +4,610 9,610 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HENNEMAN JOHN B III Director 2021-06-30 Grant or award · Stock Option (Right to Buy) +22,750 22,750 D: show line 2 in the form
Loading xslF345X03/doc1.xml…